Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sommerer

Showing results (421-430 of 427) with videos related to

Pageof 43
Sort By:
You have reached the last page of results.This site can display upto 427 results.
Journal of the American Society of Nephrology : JASN|September 22, 2022
Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant RecipientsChristian Morath, Matthias Schaier, Eman Ibrahim, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 25, 2024
Interactive exploration of adverse events and multimorbidity in CKDInga Steinbrenner, Fruzsina Kotsis, Robin Kosch, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 28, 2020
Should kidney allografts from old donors be allocated only to old recipients?Caner Süsal, Gizem Kumru, Bernd Döhler, et al.
BMJ Open|November 11, 2022
Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trialChristian Morath, Anita Schmitt, Michael Schmitt, et al.
Kidney International Reports|December 18, 2023
Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA NephropathyFrederick W K Tam, James Tumlin, Jonathan Barratt, et al.
Frontiers in Immunology|July 24, 2023
Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantationMatthias Schaier, Christian Morath, Lei Wang, et al.
Therapeutic Drug Monitoring|May 3, 2019
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus ReportMercè Brunet, Teun van Gelder, Anders Åsberg, et al.
Pageof 43

Showing results (421-430 of 427) with videos related to

Sort By:
Pageof 43
You have reached the last page of results.This site can display upto 427 results.
Journal of the American Society of Nephrology : JASN|September 22, 2022
Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant RecipientsChristian Morath, Matthias Schaier, Eman Ibrahim, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 25, 2024
Interactive exploration of adverse events and multimorbidity in CKDInga Steinbrenner, Fruzsina Kotsis, Robin Kosch, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 28, 2020
Should kidney allografts from old donors be allocated only to old recipients?Caner Süsal, Gizem Kumru, Bernd Döhler, et al.
BMJ Open|November 11, 2022
Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trialChristian Morath, Anita Schmitt, Michael Schmitt, et al.
Kidney International Reports|December 18, 2023
Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA NephropathyFrederick W K Tam, James Tumlin, Jonathan Barratt, et al.
Frontiers in Immunology|July 24, 2023
Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantationMatthias Schaier, Christian Morath, Lei Wang, et al.
Therapeutic Drug Monitoring|May 3, 2019
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus ReportMercè Brunet, Teun van Gelder, Anders Åsberg, et al.
Pageof 43